System Transmission

Top Signal

100#1 JOB

Activity

2186Ripe

+944 today

System

Livenow

Terminal Asset View

stockNASDAQ

ALDX

$4.13-11.67%

Aldeyra Therapeutics Inc

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

50Overripe

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for ALDX

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Aldeyra Therapeutics Inc creates medicines for eye conditions such as dry eye disease and allergic conjunctivitis. Doctors and patients use these treatments to reduce inflammation and improve vision. The company makes money by selling these drugs and forming partnerships with larger pharmaceutical firms.

ALD

Industry Context

Aldeyra operates in the biotechnology sector, focusing on innovative treatments for inflammatory and immune-related eye diseases. This industry is competitive, with many companies developing similar therapies, but Aldeyra's niche approach targets specific conditions with high unmet needs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

53Matrix

Market Momentum

35.0— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

2.8x— Normal Volume

Today's Change

-11.67%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

Gap Exposure-1

Large opening gap indicates potential short-term exhaustion.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ALDX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 09:10 PM UTC

As-of As of 2026-03-15T20:55:37.493Z UTC (~15m delay).

Develops innovative treatments for rare eye diseases, generating revenue through drug sales and partnerships with pharmaceutical companies.

Monthly chart shows base formation near $5, suggesting a strong foundation for potential moves. Watch for price breaking above this level.

Volume spiked 3x at $4, indicating buyer interest because it coincided with positive clinical trial news. Monitor if volume stays above average.

Industry trend toward biologic therapies is driving strength, with price holding above $4, signaling resilience. Watch for sector recovery in biotech.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...